Skip to main content
SpringerLink
Log in

Pharmacologic Management of Chronic Urticaria in Pediatric Patients: The Gap Between Guidelines and Practice

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Chronic urticaria is an uncommon disorder in children but can present considerable morbidity, as well as frustration for the healthcare provider and parent. The prevalence is 0.1–0.3% but can vary considerably by country. Chronic spontaneous urticaria (no identifiable cause) is responsible for 70–80% of chronic urticaria, about half of this due to a subtype called chronic autoimmune urticaria identified by the presence of autoantibodies to IgE or the IgE receptor. Chronic urticaria that is triggered by external physical stimuli is called chronic inducible urticaria and is present in another 15–20%. Allergies, infection, and other underlying diseases such as thyroid disease, celiac disease, or Helicobacter pylori infection cause a minor proportion of cases. Chronic urticaria has considerable impact on quality of life and healthcare costs. An adverse impact on quality of life is more prevalent in older children and adolescents and can be comparable to other diseases of childhood such as diabetes and epilepsy. Healthcare costs can be 50% higher than the national estimates for healthy patients and include more hospitalizations, longer duration of hospitalizations, and more emergency department (ED) and outpatient visits. Allergic and autoimmune diseases can be comorbidities that add to healthcare utilization. Resolution can take years. Guidelines are available for diagnosis and treatment. A good history is the key to identifying the cause. Minimal laboratory tests are required and should be guided by the history. Patients with easily controlled urticaria may not need any laboratory tests. Suggested treatment emphasizes the use of non-sedating antihistamines, utilized in a step-wise fashion beginning with normal doses and advancing the dose based on the response up to four times the recommended dose for age. Other treatments are left to the urticaria specialist and are not discussed in this paper. These guidelines are not well utilized based on real-world studies; sedating antihistamines and oral steroids are overutilized. Medications should be taken daily, not as needed. Additional medications, if required, should be added to prior medications in a step-wise fashion. The gap between the guidelines for diagnosis and treatment and what is happening in the real world needs to be closed to reduce the cost and morbidity associated with this disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Church MK, Weller K, Stock P, Maurer M. Chronic spontaneous urticaria in children: itching for insight. Pediatr Allergy Immunol. 2011;22:1–8.

    PubMed  Google Scholar 

  2. Caffarelli C, Cuomo B, Cardinale F, et al. Aetiological factors associated with chronic urticaria in children: a systematic review. Acta Derm Venereol. 2013;93:268–72.

    PubMed  Google Scholar 

  3. Ball M-M, Weller K, Carboni V, et al. Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients. Pediatr Allergy Immunol. 2018;29:630–6.

    Google Scholar 

  4. Lee SJ, Ha EK, Lee HM, et al. Prevalence and risk factors of urticaria with a focus on chronic urticaria in children. Allergy Asthma Immunol Res. 2017;9:212–9.

    PubMed  PubMed Central  Google Scholar 

  5. Choi SH, Baek HS. Approaches to the diagnosis and management of chronic urticaria in children. Korean J Pediatr. 2015;58:159–64.

    PubMed  PubMed Central  Google Scholar 

  6. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. The 2017 revision and update. Allergy. 2018;73(5):1393–414.

    CAS  PubMed  Google Scholar 

  7. Kilic G, Guler N, Suleyman A, Tamay Z. Chronic urticaria and autoimmunity in children. Pediatr Allergy Immunol. 2010;21:837–42.

    PubMed  Google Scholar 

  8. Mari A. Allergy-like asthma and rhinitis. A cross-sectional survey of a respiratory cohort and a diagnostic approach using the autologous serum skin test. Int Arch Allergy Immunol. 2004;133:29–39.

    PubMed  Google Scholar 

  9. Powell RJ, Leech SC, Till S, et al. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2015;45:547–65.

    CAS  PubMed  Google Scholar 

  10. Marrouche N, Grattan C. Childhood urticaria. Curr Opin Allergy Clin Immunol. 2012;12:485–90.

    CAS  PubMed  Google Scholar 

  11. Zuberbier T, Bernstein JA. A comparison of the United States and international perspective of chronic urticaria guidelines. J Allergy Clin Immunol Pract. 2018;6:1144–51.

    PubMed  Google Scholar 

  12. Ben-Shoshone M, Grattan CE. Management of pediatric urticaria with review of the literature on chronic spontaneous urticaria in children. J Allergy Clin Immunol Pract. 2018;6:1152–61.

    Google Scholar 

  13. Ferriani MPL, Silva MFC, Pereira RMR, et al. Chronic spontaneous urticaria: a survey of 852 cases of childhood-onset systemic lupus erythematosus. Int Arch Allergy Immunol. 2015;167:186–92.

    CAS  PubMed  Google Scholar 

  14. Lin C-H, Hung P-H, Hu H-Y. Clinically diagnosed urticaria and risk of systemic lupus erythematosus in children: a nationwide population-based case-control study. Pediatr Allergy Immunol. 2018;29:732–9.

    PubMed  Google Scholar 

  15. Zitelli KB, Cordoro KM. Evidence-based evaluation and management of chronic urticaria in children. Pediatr Dermatol. 2011;28:629–39.

    PubMed  Google Scholar 

  16. Akelma AZ, Cizmeci MN, Mete E, et al. A neglected cause for chronic spontaneous urticaria in children: Helicobacter pylori. Allergol Immunopathol (Madr). 2015;43(3):259–63.

    CAS  Google Scholar 

  17. Hsu M-L, Li L-F. Prevalence of food avoidance and food allergy in Chinese patients with chronic urticaria. Br J Dermatol. 2012;166:747–52.

    PubMed  Google Scholar 

  18. Kennedy JL, Stallings AP, Platts-Mills TAE, et al. Galactose-alpha-1,3-galactose and delayed anaphylaxis, angioedema and urticaria in children. Pediatrics. 2013;131:e1545–52.

    PubMed  PubMed Central  Google Scholar 

  19. Kolkhir P, Balakirski G, Merk F, et al. Chronic spontaneous urticaria and internal parasites—a systematic review. Allergy. 2016;71:308–22.

    CAS  PubMed  Google Scholar 

  20. Cavkaytar O, Yilmaz A, Buyuktiryaki B, et al. Challenge-proven aspirin sensitivity in children with chronic spontaneous urticaria. Allergy. 2015;70:153–60.

    CAS  PubMed  Google Scholar 

  21. Gimenez-Arnau AM, Grattan C, Zuberbier T, Toubi E. An individualized diagnostic approach based on guidelines for chronic urticaria (CU). JEADV. 2015;29(suppl 3):3–11.

    PubMed  Google Scholar 

  22. Ferrer M. Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. J Investig Allergol Clin Immunol. 2009;19(Suppl 2):21–6.

    PubMed  Google Scholar 

  23. Chansakulporn S, Pongpreuksa S, Sangacharoenkit P, et al. The natural history of chronic urticaria in childhood: a prospective study. J Am Acad Dermatol. 2014;71:663–8.

    PubMed  Google Scholar 

  24. Maurer M, Church MK, Weller K. Chronic urticaria in children. Still itching for insight. JAMA Dermatol. 2017;153:1221–2.

    PubMed  Google Scholar 

  25. Eser I, Yologlu N, Baydemir C, et al. The predictive factors for remission of chronic spontaneous urticaria in childhood: outcome from a prospective study. Allergol Immunopathol (Madr). 2016;44:537–41.

    CAS  Google Scholar 

  26. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F, Gonzalez-Aveledo L. Biomarkers of treatment efficacy in patients with chronic spontaneous urticaria. Eur Ann Allergy Clin Immunol. 2018;50:5–9.

    CAS  PubMed  Google Scholar 

  27. Broder MS, Raimundo K, Antonova E, Chang E. Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria. Am J Clin Dermatol. 2015;16:313–21.

    PubMed  PubMed Central  Google Scholar 

  28. Williams PV, Kavati A, Pilon D, et al. Treatment patterns, healthcare resource utilization, and spending among Medicaid-enrolled children with chronic idiopathic/spontaneous urticaria in the United States. Dermatol Ther (Heidelb). 2018;8:69–83.

    Google Scholar 

  29. Williams P, Kavati A, Pilon D, et al. Healthcare burden and treatment patterns in commercially-insured children with chronic idiopathic/spontaneous urticaria: a real-world study in the United States. Allergy Asthma Proc. 2018;39:201–11.

    PubMed  Google Scholar 

  30. Cornillier H, Giraudeau B, Munck S, et al. Chronic spontaneous urticaria in children—a systematic review on interventions and comorbidities. Pedtiatr Allergy Immunol. 2018;29:303–10.

    Google Scholar 

  31. Netchiporouk E, Sasseville D, Moreau L, et al. Evaluating Comorbidities, natural history and predictors of early resolution in a cohort of children with chronic urticaria. JAMA Dermatol. 2017;153:1236–42.

    PubMed  PubMed Central  Google Scholar 

  32. Salo PM, Arbes SJ, Jaramillo R, et al. Prevalence of allergic sensitization in the United States: results from the National Health and Nutrition Examination Survey (NHANES) 2005–2006. J Allergy Clin Immunol. 2014;134:350–9.

    PubMed  PubMed Central  Google Scholar 

  33. Morikawa E, Sasaki M, Yoshida K, et al. Nationwide survey of the prevalence of wheeze, rhino-conjunctivitis, and eczema among Japanese children in 2015. Allergol Int. 2019. https://doi.org/10.1016/j.alit.2019.08.010.

    Article  PubMed  Google Scholar 

  34. Sacchetti M, Regine V, Mantelli F, et al. Allergy screening in schoolchildren-based population. Pediatr Allergy Immunol. 2019;30:289–95.

    PubMed  Google Scholar 

  35. Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133:1270–7.

    PubMed  Google Scholar 

  36. Kolkhir P, Metz M, Altrichter S, Maurer M. Comorbidity of chronic spontaneous urticaria and thyroid diseases: a systematic review. Allergy. 2017;72:1440–60.

    CAS  PubMed  Google Scholar 

  37. Fasano MB, Peden DB, Busse PJ, et al. American Academy of Allergy, Asthma and Immunology response to the EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria 2017 revision. Allergy. 2018;74:411–3.

    PubMed  Google Scholar 

  38. Sharma M, Bennett C, Cohen SN, et al. H1-antihistamines for chronic spontaneous urticaria. Cochrane Database Syst Rev. 2014;11:CD006137.

    Google Scholar 

  39. Lee XHM, Ong LX, Cheong JYV, et al. A stepwise approach in the management of chronic spontaneous urticaria in children. Asia Pac Allergy. 2016;6:16–28.

    PubMed  PubMed Central  Google Scholar 

  40. Fitzsimons R, van der Poel LA, Thornhill W, et al. Antihistamine use in children. Arch Dis Child Educ Pract Ed. 2015;100:122–31.

    PubMed  Google Scholar 

  41. Weller K, Zuberbier T, Maurer M. Chronic urticaria: tools to aid the diagnosis and assessment of disease status in daily practice. JEADV. 2015;29(Suppl 3):38–44.

    PubMed  Google Scholar 

  42. Weller K, Groffik A, Church MK, et al. Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014;133:1365–72.

    PubMed  Google Scholar 

  43. Caffarelli C, Paravati F, El Hachem M, et al. Management of chronic urticaria in children: a clinical guideline. Ital J Pediatr. 2019;45(1):101.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Allergy Division, University of Washington School of Medicine, Seattle, WA, USA

    Paul V. Williams

  2. Northwest Asthma & Allergy Center, 10333 19th Ave SE, Suite 105, Everett, WA, 98208, USA

    Paul V. Williams

Authors
  1. Paul V. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul V. Williams.

Ethics declarations

Conflict of interest

Paul V. Williams is employed by Northwest Asthma and Allergy Center. He is a previous consultant to Novartis on pediatric urticaria, for whom he participated in study design and manuscript preparation on real world treatment of pediatric urticaria.

Funding

No funding was received to assist with the preparation of this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Williams, P.V. Pharmacologic Management of Chronic Urticaria in Pediatric Patients: The Gap Between Guidelines and Practice. Pediatr Drugs 22, 21–28 (2020). https://doi.org/10.1007/s40272-019-00365-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40272-019-00365-3

Search

Navigation